CLINICAL_TRIALS
trial_result
· 2007-12-31
Clinical Trial Update: Open-Label Duloxetine Monotherapy in the Treatment of Posttraumatic Stress Disorder [Phase 3]
Summary
Open-label Phase 3 study of duloxetine as monotherapy for Posttraumatic Stress Disorder.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Canive, Jose M., M.D. | Conditions: Posttraumatic Stress Disorders | Phase 3 | Status: UNKNOWN